Drug intelligence / Profile preview

SpeedGel Rx

Development stage
Unknown
Lead developer
Gensco Laboratories
Modality
Small Molecules
Administration
Topical, Transdermal
01

Overview

SpeedGel Rx is a prescription topical transdermal gel developed by Gensco Pharma for the relief of pain, inflammation, and bruising associated with musculoskeletal conditions, arthritis, and soft tissue injuries. It is formulated as a non-NSAID alternative, utilizing Gensco's patented Isopeutic Transdermal Technology to deliver a combination of 14 active homeopathic ingredients directly to affected tissues. Regulated under the Homeopathic Pharmacopeia of the United States (HPUS), the product contains botanical and mineral-derived components such as *Arnica montana*, *Echinacea*, and *Colchicinum*. SpeedGel Rx aims to provide localized analgesic and anti-inflammatory effects while minimizing the systemic side effects typically associated with oral therapies or topical NSAIDs. It is dispensed in a patented metered-dose (MDose) container to ensure precise application and consistent dosing.

Brand names
SpeedGel Rx

Beyond the preview

Go deeper on SpeedGel Rx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpeedGel Rx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call